The inconsistencies are likely attributable to the fact that each study focused on only a few aspects of the DDR (such as apoptosis or the cell cycle response) [12]–[15] and each used cancer cell lines with different genetic backgrounds; hence, the effects of aberrations in genes other than TP53 may have masked the results [12], [13]. Here, TP53 is linked to cancer.